We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 21-40 of 9,660 results
  1. CM-Path Molecular Diagnostics Forum—consensus statement on the development and implementation of molecular diagnostic tests in the United Kingdom

    Background

    Pathology has evolved from a purely morphological description of cellular alterations in disease to our current ability to interrogate...

    Philip S. Macklin, Nischalan Pillay, ... Clare Verrill in British Journal of Cancer
    Article Open access 02 October 2019
  2. KRAS is a molecular determinant of platinum responsiveness in glioblastoma

    Background

    KRAS is the undisputed champion of oncogenes, and despite its prominent role in oncogenesis as mutated gene, KRAS mutation appears...

    Candida Zuchegna, Stefano Leone, ... Samantha Messina in BMC Cancer
    Article Open access 15 January 2024
  3. Benefits of applying molecular barcoding systems are not uniform across different genomic applications

    Background

    Despite the wide variety of Next Generation Sequencing (NGS)-based methods, it remains challenging to detect mutations present at very low...

    Jonathan Bieler, Slawomir Kubik, ... Zhenyu Xu in Journal of Translational Medicine
    Article Open access 05 May 2023
  4. Untargeted metabolomic profiling reveals molecular signatures associated with type 2 diabetes in Nigerians

    Background

    Type 2 diabetes (T2D) has reached epidemic proportions globally, including in Africa. However, molecular studies to understand the...

    Ayo P. Doumatey, Daniel Shriner, ... Charles N. Rotimi in Genome Medicine
    Article Open access 05 March 2024
  5. Dentate gyrus astrocytes exhibit layer-specific molecular, morphological and physiological features

    Neuronal heterogeneity has been established as a pillar of higher central nervous system function, but glial heterogeneity and its implications for...

    Julian Karpf, Petr Unichenko, ... Ruth Beckervordersandforth in Nature Neuroscience
    Article 28 November 2022
  6. Diagnostics and Personalized Medicine

    The drug discovery landscape is changing with the advent of personalized medicine and the companion diagnostics that are used to select patients who...
    Chapter 2020
  7. A molecular toolbox for fast and convenient diagnosis of emerging and reemerging bacterial pathogens causing fever of intermediate duration

    Purpose

    Fever of intermediate duration (FID) is defined as a fever in the community without a specific origin or focus, with a duration between 7 and...

    Elva Vega-García, Génesis Palacios, ... Emma Carmelo in European Journal of Clinical Microbiology & Infectious Diseases
    Article Open access 25 January 2024
  8. Systematic in vitro analysis of therapy resistance in glioblastoma cell lines by integration of clonogenic survival data with multi-level molecular data

    Despite intensive basic scientific, translational, and clinical efforts in the last decades, glioblastoma remains a devastating disease with a highly...

    Leon Emanuel Schnöller, Daniel Piehlmaier, ... Michael Orth in Radiation Oncology
    Article Open access 11 March 2023
  9. Molecular alterations and clinical prognostic factors in resectable non-small cell lung cancer

    Background

    EGFR inhibitor and immunotherapy have been approved for adjuvant treatment in resectable non-small cell lung cancer (NSCLC). Limited...

    T. Thamrongjirapat, D. Muntham, ... T. Reungwetwattana in BMC Cancer
    Article Open access 13 February 2024
  10. Molecular epidemiology and diagnostics of KRAS mutations in human cancer

    RAS mutation is the most frequent oncogenic alteration in human cancers. KRAS is the most frequently mutated followed by NRAS. The emblematic KRAS...

    Jozsef Timar, Karl Kashofer in Cancer and Metastasis Reviews
    Article Open access 29 July 2020
  11. Molecular Progression of Breast Cancer and Personalized Medicine in Terms of Clinical Trials

    Breast cancer (BC) is well-known for its diversified clinical behaviors despite the similar histopathological characteristics at diagnosis. Research...
    Somia Liaqat, Mubashar Hussain, ... Saima Shakil Malik in Breast Cancer: From Bench to Personalized Medicine
    Chapter 2022
  12. The Opportunities and Challenges of Molecular Tagging Next-Generation Sequencing in Liquid Biopsy

    Liquid biopsy (LB) is a promising tool that is rapidly evolving as a standard of care in early and advanced stages of cancer settings....

    Giuseppa De Luca, Mariella Dono in Molecular Diagnosis & Therapy
    Article 05 July 2021
  13. Overcoming Clinical Research Disparities by Advancing Inclusive Research

    Achieving personalized healthcare for all people, including the most vulnerable Hispanic communities, may appear to be an insurmountable task or an...
    Chapter Open access 2023
  14. An integrated multi-omic approach demonstrates distinct molecular signatures between human obesity with and without metabolic complications: a case–control study

    Objectives

    To examine the hypothesis that obesity complicated by the metabolic syndrome, compared to uncomplicated obesity, has distinct molecular...

    Fayaz Ahmad Mir, Raghvendra Mall, ... Abdul-Badi Abou-Samra in Journal of Translational Medicine
    Article Open access 29 March 2023
  15. Insulin receptor expression to predict resistance to axitinib and elucidation of the underlying molecular mechanism in metastatic renal cell carcinoma

    Background

    The study aimed to examine the significance of insulin receptor (INSR) expression in predicting resistance to axitinib in clear cell renal...

    Masayuki Takahashi, Kei Daizumoto, ... Hiroomi Kanayama in British Journal of Cancer
    Article 24 June 2023
  16. Molecular Diagnosis of Primary Cardiomyopathy in 231 Unrelated Pediatric Cases by Panel-Based Next-Generation Sequencing: A Major Focus on Five Carriers of Biallelic TNNI3 Pathogenic Variants

    Background and Objective

    Pediatric cardiomyopathies are clinically heterogeneous heart muscle disorders associated with significant morbidity and...

    Alexandre Janin, Thomas Perouse de Montclos, ... Gilles Millat in Molecular Diagnosis & Therapy
    Article 15 July 2022
  17. Molecular profiling identifies targeted therapy opportunities in pediatric solid cancer

    To evaluate the clinical impact of molecular tumor profiling (MTP) with targeted sequencing panel tests, pediatric patients with extracranial solid...

    Alanna J. Church, Laura B. Corson, ... Katherine A. Janeway in Nature Medicine
    Article 23 June 2022
  18. Automation Techniques in Mycobacteriology

    In this era of globalisation and pandemics, automation in clinical laboratories is in huge demand as it enhances the workflow process. Laboratory...
    Vineeta Mittal, Pranshu Pandey, Niharika Pandey in Automated Diagnostic Techniques in Medical Microbiology
    Chapter 2024
  19. An integrated approach of network pharmacology, molecular docking, and experimental verification uncovers kaempferol as the effective modulator of HSD17B1 for treatment of endometrial cancer

    Background

    Endometrial cancer (EC) is one of the most common gynecological malignancies globally, and the development of innovative, effective drugs...

    Guan-Yu Ruan, Li-**ang Ye, ... Peng-Ming Sun in Journal of Translational Medicine
    Article Open access 17 March 2023
  20. Diagnostic Accuracy of Two Molecular Tools for Diagnosis of Congenital Chagas Disease

    Background and Objective

    The real prevalence of congenital Chagas disease is undefined because of difficulties in the detection of Trypanosoma cruzi ...

    Margarita María Catalina Bisio, Rocío Rivero, ... Jaime Altcheh in Molecular Diagnosis & Therapy
    Article 23 August 2021
Did you find what you were looking for? Share feedback.